🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Find out my latest paper in The ASCO Post on some advances in cancer research advances in LMICs Khalid El Bairi, MD #ASCOPost #GlobalOncology #LMICs ascopost.com/issues/decembe…

Trial in Progress. Phase Ib/II - IIT - Single dose of Durvalumab in non-surgical pts proposed for RT/CRT. #poster949TiP #ESMO22 #earlyphasetrials #ipoporto

"This is a waterfall plot..." NICHE-2 - Neoadjuvant IO in Colorectal MMRd Congrats Myriam Chalabi and team!! 👏👏👏👏👏😍 #ESMO22 #Immunotherapy

🔊🎯 #precisiononcology in mCSPC 💭Helping in treatment selection ✅SPOP mut ---> ADT + Androgen Targeted Therapy ❌SPOPwt ---> Docetaxel Incredible work by Umang Swami and team 👏👏

📢IO far beyond the usual suspects PDL1/CTLA4 Durvalumab vs. Durvalumab + monalizumab (activator NKG2A) vs. Durvalumab + Oleclumab (anti CD-73) ⭐12mo PFS 33,9% vs. 72,7% vs. 62,6%⭐ Showing again that combinations are 🔑 in #Immunotherapy #clinicaltrials

Our Phase 1 unit is growing in patients and space 🎯🧬🧪 We treat 300 patients-year in our Early Phase Clinical Trials Unit and we expect to double the numbers soon. #earlyclinicaltrialsunit #ipoporto publico.pt/2022/10/24/cie…

It was and honor to be invited to talk about clinical relevance of PD-L1 to #pathology technicians and collegues🧪🧬 📢 We need standard clone/test! #pdl1 #Immunotherapy

Good morning from #Zurich ☀️ It's an honor to be representing 🇵🇹 at ESMO - Eur. Oncology Advanced Course on Biomarkers for Precision Cencer Medicine, with all this collegues from all over Europe 🇪🇺 Almost a World Cup of #precisiononcology ⚽🎯!!

Glad to spend the day learning more about #precisiononcology at Faculdade de Medicina, Universidade do Porto 1st Fórum of Precision Oncology in Portugal 🇵🇹 Giving the right drug, to the right patient, at the right time 🎯 #endcancer

Yesterday I was honored to give a talk to students from Master's Degree in Oncology from Instituto de Ciências Biomédicas Abel Salazar UP on: "How to create/design a clinical trial? Perspective from early phase trials" Young minds enthusiastic about Oncology 👏👏 IPO Porto #earlyphaseunit

Watch to learn how increased cell densities of Tregs affect risk for disease recurrence and progression in nodular lymphocyte predominant Hodgkin lymphoma, from our Dr. Mario Marques-Piubelli. @Mario_Pathology #ASH22 #EndCancer

Greetings again from Zurich 🇨🇭 With this Christmas background ❄️🎄 Learning and debating ideas about Immunotherapy in Oncology 🦀 Made possible by @esmo, with FabriceAndre, Solange Peters , Andres Cervantes and chaired by the great Inge Marie Svane from CCIT, Kobenhavns, Denmark

Is it just me or is this #ASCOGU23 the definitely congress of PARPi in prostate cancer? OncoAlert Oncology Brothers

Looking forward to present our work at #aacr23 done at MD Anderson Cancer Center Just pass by poster area sunday 16th april so we can chat on🎯🦀 Abstract 963: Clinical impact of MTAP status in advanced cholangiocarcinoma: Genomic profile and response to treatment aacrjournals.org/cancerres/arti…

A new paper published in Nature Medicine by Drs. gelareh-zadeh and Farshad Nassiri University Health Network Temerty Medicine using a novel combination approach to #glioblastoma treatment shows promise, extending survival. Learn more: bit.ly/41SFlkB #BrainTumorAwarenessMonth #Braintumor

Heading to #ccesummerschool by 🚅🤓 Looking forward for a week full of cancer science and to meet oncologist from over Europe in a beautiful spot such as @praiadafalesia 🏖️ #algarve x.com/CancerCoreEU/s…

What an amazing week at Cancer Core Europe Summer School 2023 with science and fun uniting 71 cancer researchers and clinicians from 31 nationalities! Such a rich program with focus on AI, IO, TME and MTB 🧪🦀🎯 #translationaloncology #CancerResearch #algarve #portugal

Today I had the privilege to give a talk about Molecular Oncology at IPO Porto Genomic profiling of rare cancers is key to identify targetable genomic alterations that could make a significant difference in the lives of these patients. #molecularoncology #ipoporto #earlytrials

It was an honor to participate in this project while at MD Anderson Cancer Center with an amazing team (Natalie Ngoi, Dr. Shubham Pant, Milind Javle) under the mentorship of the incredible Jordi Rodon🏅 MTAP loss in GI cancers is frequent and druggable!🎯 academic.oup.com/oncolo/article…

Gratefull to be here in Toronto 🇨🇦🍁 Princess Margaret Cancer Centre Research learning from the best in drug development and translational research 💊🧬 Wouldn't be possible without the support of CRIS contra el cáncer and confidence of Lillian Siu